Correlation Between Jpmorgan Growth and Sarofim Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jpmorgan Growth and Sarofim Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jpmorgan Growth and Sarofim Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jpmorgan Growth Advantage and Sarofim Equity, you can compare the effects of market volatilities on Jpmorgan Growth and Sarofim Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jpmorgan Growth with a short position of Sarofim Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jpmorgan Growth and Sarofim Equity.

Diversification Opportunities for Jpmorgan Growth and Sarofim Equity

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Jpmorgan and Sarofim is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Jpmorgan Growth Advantage and Sarofim Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarofim Equity and Jpmorgan Growth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jpmorgan Growth Advantage are associated (or correlated) with Sarofim Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarofim Equity has no effect on the direction of Jpmorgan Growth i.e., Jpmorgan Growth and Sarofim Equity go up and down completely randomly.

Pair Corralation between Jpmorgan Growth and Sarofim Equity

Assuming the 90 days horizon Jpmorgan Growth Advantage is expected to generate 1.93 times more return on investment than Sarofim Equity. However, Jpmorgan Growth is 1.93 times more volatile than Sarofim Equity. It trades about 0.07 of its potential returns per unit of risk. Sarofim Equity is currently generating about 0.07 per unit of risk. If you would invest  3,619  in Jpmorgan Growth Advantage on September 16, 2024 and sell it today you would earn a total of  199.00  from holding Jpmorgan Growth Advantage or generate 5.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Jpmorgan Growth Advantage  vs.  Sarofim Equity

 Performance 
       Timeline  
Jpmorgan Growth Advantage 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Jpmorgan Growth Advantage are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward-looking indicators, Jpmorgan Growth is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Sarofim Equity 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sarofim Equity are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong primary indicators, Sarofim Equity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Jpmorgan Growth and Sarofim Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jpmorgan Growth and Sarofim Equity

The main advantage of trading using opposite Jpmorgan Growth and Sarofim Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jpmorgan Growth position performs unexpectedly, Sarofim Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarofim Equity will offset losses from the drop in Sarofim Equity's long position.
The idea behind Jpmorgan Growth Advantage and Sarofim Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios